METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
Abstract Background Neuroblastoma (NBL) is the most common extra-cranial solid tumour in childhood, with prognosis ranging from spontaneous remission to high risk for rapid and fatal progression. Despite existing therapy approaches, the 5-year event-free survival (EFS) for patients with advanced NBL...
Main Authors: | Ying Huang, Jieyi Ma, Cuiyun Yang, Paijia Wei, Minghui Yang, Hui Han, Hua Dong Chen, Tianfang Yue, Shu Xiao, Xuanyu Chen, Zuoqing Li, Yanlai Tang, Jiesi Luo, Shuibin Lin, Libin Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-022-00414-z |
Similar Items
-
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
by: Raquel García-Vílchez, et al.
Published: (2023-07-01) -
Epigenetic Dysregulation in <i>MYCN</i>-Amplified Neuroblastoma
by: Soraya Epp, et al.
Published: (2023-12-01) -
Understanding the role of PRMT5 in neuroblastoma
by: Albayrak, G
Published: (2023) -
Expression and Potential Biomarkers of Regulators for M7G RNA Modification in Gliomas
by: Zhen Chen, et al.
Published: (2022-05-01) -
bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma
by: Jingjing Song, et al.
Published: (2022-09-01)